The adjustment in price target by a reputable analyst firm like Raymond James could have a mixed impact on DCOM's stock price. While maintaining an Outperform rating indicates a positive outlook on the stock, the reduction in the price target might signal a tempered expectation for the stock's short-term growth potential. Investors might react cautiously to this news, leading to a neutral short-term impact.